Landis, S.H., Murray, T., Bolden, S. & Wingo, P.A. Cancer statistics, 1999. CA Cancer J. Clin. 49, 8–31 (1999).
Ford, D. et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 62, 676–689 (1998).
Turner, N.C. et al. BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 26, 2126–2132 (2007).
Catteau, A. & Morris, J.R. BRCA1 methylation: a significant role in tumour development? Semin. Cancer Biol. 12, 359–371 (2002).
Wilson, C.A. et al. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat. Genet. 21, 236–240 (1999).
Xu, C.F., Chambers, J.A. & Solomon, E. Complex regulation of the BRCA1 gene. J. Biol. Chem. 272, 20994–20997 (1997).
Rice, J.C., Massey-Brown, K.S. & Futscher, B.W. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene 17, 1807–1812 (1998).
Mueller, C.R. & Roskelley, C.D. Regulation of BRCA1 expression and its relationship to sporadic breast cancer. Breast Cancer Res. 5, 45–52 (2003).
Bindra, R.S. et al. Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res. 65, 11597–11604 (2005).
De Siervi, A. et al. Transcriptional autoregulation by BRCA1. Cancer Res. 70, 532–542 (2010).
Deng, C.X. BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res. 34, 1416–1426 (2006).
Mullan, P.B., Quinn, J.E. & Harkin, D.P. The role of BRCA1 in transcriptional regulation and cell cycle control. Oncogene 25, 5854–5863 (2006).
Spillman, M.A. & Bowcock, A.M. BRCA1 and BRCA2 mRNA levels are coordinately elevated in human breast cancer cells in response to estrogen. Oncogene 13, 1639–1645 (1996).
Marks, J.R. et al. BRCA1 expression is not directly responsive to estrogen. Oncogene 14, 115–121 (1997).
Lane, T.F. et al. Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice. Genes Dev. 9, 2712–2722 (1995).
Gorski, J.J., Kennedy, R.D., Hosey, A.M. & Harkin, D.P. The complex relationship between BRCA1 and ERα in hereditary breast cancer. Clin. Cancer Res. 15, 1514–1518 (2009).
Chinnadurai, G. The transcriptional corepressor CtBP: a foe of multiple tumor suppressors. Cancer Res. 69, 731–734 (2009).
Turner, N., Tutt, A. & Ashworth, A. Hallmarks of 'BRCAness' in sporadic cancers. Nat. Rev. Cancer 4, 814–819 (2004).
Gorski, J.J. et al. BRCA1 transcriptionally regulates genes associated with the basal-like phenotype in breast cancer. Breast Cancer Res. Treat. 122, 721–731 (2010).
Fjeld, C.C., Birdsong, W.T. & Goodman, R.H. Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor. Proc. Natl. Acad. Sci. USA 100, 9202–9207 (2003).
Zhang, Q., Piston, D.W. & Goodman, R.H. Regulation of corepressor function by nuclear NADH. Science 295, 1895–1897 (2002).
Kim, T.H. et al. A high-resolution map of active promoters in the human genome. Nature 436, 876–880 (2005).
Ferreira, R., Magnaghi-Jaulin, L., Robin, P., Harel-Bellan, A. & Trouche, D. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc. Natl. Acad. Sci. USA 95, 10493–10498 (1998).
Cunliffe, V.T. Eloquent silence: developmental functions of Class I histone deacetylases. Curr. Opin. Genet. Dev. 18, 404–410 (2008).
Wang, A., Schneider-Broussard, R., Kumar, A.P., MacLeod, M.C. & Johnson, D.G. Regulation of BRCA1 expression by the Rb-E2F pathway. J. Biol. Chem. 275, 4532–4536 (2000).
Zhang, Q., Yao, H., Vo, N. & Goodman, R.H. Acetylation of adenovirus E1A regulates binding of the transcriptional corepressor CtBP. Proc. Natl. Acad. Sci. USA 97, 14323–14328 (2000).
Yu, X., Wu, L.C., Bowcock, A.M., Aronheim, A. & Baer, R. The C-terminal (BRCT) domains of BRCA1 interact in vivo with CtIP, a protein implicated in the CtBP pathway of transcriptional repression. J. Biol. Chem. 273, 25388–25392 (1998).
Aprelikova, O.N. et al. BRCA1-associated growth arrest is RB-dependent. Proc. Natl. Acad. Sci. USA 96, 11866–11871 (1999).
Fan, S. et al. Disruption of BRCA1 LXCXE motif alters BRCA1 functional activity and regulation of RB family but not RB protein binding. Oncogene 20, 4827–4841 (2001).
Saunders, A., Core, L.J. & Lis, J.T. Breaking barriers to transcription elongation. Nat. Rev. Mol. Cell Biol. 7, 557–567 (2006).
Aiyar, S.E. et al. Attenuation of estrogen receptor α-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor. Genes Dev. 18, 2134–2146 (2004).
Rahl, P.B. et al. c-Myc regulates transcriptional pause release. Cell 141, 432–445 (2010).
Stossi, F., Madak-Erdogan, Z. & Katzenellenbogen, B.S. Estrogen receptor α represses transcription of early target genes via p300 and CtBP1. Mol. Cell. Biol. 29, 1749–1759 (2009).
Xu, C.F. et al. Distinct transcription start sites generate two forms of BRCA1 mRNA. Hum. Mol. Genet. 4, 2259–2264 (1995).
Lin, J.M. et al. Transcription factor binding and modified histones in human bidirectional promoters. Genome Res. 17, 818–827 (2007).
Brooks, R.F. Continuous protein synthesis is required to maintain the probability of entry into S phase. Cell 12, 311–317 (1977).
Rodríguez-Enriquez, S. et al. Control of cellular proliferation by modulation of oxidative phosphorylation in human and rodent fast-growing tumor cells. Toxicol. Appl. Pharmacol. 215, 208–217 (2006).
Meng, A.X. et al. Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells. Radiother. Oncol. 76, 168–176 (2005).
Schones, D.E. et al. Dynamic regulation of nucleosome positioning in the human genome. Cell 132, 887–898 (2008).
Andres, J.L. et al. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents. Oncogene 16, 2229–2241 (1998).
Stöckl, P., Hutter, E., Zwerschke, W. & Jansen-Durr, P. Sustained inhibition of oxidative phosphorylation impairs cell proliferation and induces premature senescence in human fibroblasts. Exp. Gerontol. 41, 674–682 (2006).
Zong, W.X., Ditsworth, D., Bauer, D.E., Wang, Z.Q. & Thompson, C.B. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev. 18, 1272–1282 (2004).
Zhang, Q., Yoshimatsu, Y., Hildebrand, J., Frisch, S.M. & Goodman, R.H. Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. Cell 115, 177–186 (2003).
Semenza, G.L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29, 625–634 (2010).
Trinklein, N.D. et al. An abundance of bidirectional promoters in the human genome. Genome Res. 14, 62–66 (2004).
Ramirez-Carrozzi, V.R. et al. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 138, 114–128 (2009).
Byun, J.S. et al. Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes. Proc. Natl. Acad. Sci. USA 106, 19286–19291 (2009).
Jang, M.K. et al. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol. Cell 19, 523–534 (2005).
Zippo, A. et al. Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation. Cell 138, 1122–1136 (2009).
Tan-Wong, S.M., French, J.D., Proudfoot, N.J. & Brown, M.A. Dynamic interactions between the promoter and terminator regions of the mammalian BRCA1 gene. Proc. Natl. Acad. Sci. USA 105, 5160–5165 (2008).
Driggers, P.H. & Segars, J.H. Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling. Trends Endocrinol. Metab. 13, 422–427 (2002).
Fullwood, M.J. et al. An oestrogen-receptor-α-bound human chromatin interactome. Nature 462, 58–64 (2009).
Jeffy, B.D. et al. An estrogen receptor-α/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription. Neoplasia 7, 873–882 (2005).
Hockings, J.K., Degner, S.C., Morgan, S.S., Kemp, M.Q. & Romagnolo, D.F. Involvement of a specificity proteins-binding element in regulation of basal and estrogen-induced transcription activity of the BRCA1 gene. Breast Cancer Res. 10, R29 (2008).
Fan, S. et al. p300 Modulates the BRCA1 inhibition of estrogen receptor activity. Cancer Res. 62, 141–151 (2002).
Blackshear, P.E. et al. Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice. Oncogene 16, 61–68 (1998).
Thiery, J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2, 442–454 (2002).
Cleary, M.P. & Grossmann, M.E. Obesity and breast cancer: the estrogen connection. Endocrinology 150, 2537–2542 (2009).